With many markets fast running out of product and occupiers desperate to expand, there is only one way to create more product – build it. Given the market dynamics it should be a fine time for developers to make hay. But getting the right sites under control and warehouses out of the ground, while maintaining a healthy profit margin amid fierce competition is no easy feat.
The challenge for investors eager to access the booming life sciences market is that there is very little stock to buy, and competition is intense for the assets that do come up for sale. The obvious solution to this problem is to build new labs or convert existing properties. Join React News’ analysis editor Guy Montague-Jones and a panel of leading experts as we explore how best to pursue successful redevelopments for life sciences.
London’s future prospects as a global centre of business hinge on its ability to move with the times. Property owners whose portfolio includes investments that make a positive social and environmental impact will not only attract an ever-growing pool of buyers who are focused on the best buildings with superior ESG credentials, but also the interest of ever more discerning occupiers. Those with outdated buildings on their books and without a forward-thinking approach to development will get left behind. But with so many jumping on the ESG bandwagon, what are London’s property owners doing to stand out to investors and occupiers?